Avestin Inc.
Ottawa, ON Doing business as Varasmus (Div OF)
- UEI
- PU2WZHYHTL85
- CAGE
- L0ZC1
- Primary NAICS
- 333996 Fluid Power Pump and Motor Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2450 Don Reid Dr, Ottawa, ON K1H 1E1, Canada
- Website
- avestin.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Avestin emulsiflex-C3 | Bureau of Medicine and Surgery | $35,279 | |
| High pressure homogenizer | National Institute on Drug Abuse | $31,142 | |
| Emulsiflex-C3 high-pressure homogenizer/cell disruptor instrument | Food and Drug Administration | $25,000 | |
| Purchase of the emulsiflex-C5 high pressure homogenizer for COVID19 research project on sars-COV2 n-protein interactions | National Heart Lung and Blood Institute | $22,733 | |
| Emulsiflex-C3 high pressure homogenizer with stainless steel cooling coil and shipping. | Midwest Area | $28,979 |
About Avestin Inc.
Avestin Inc., operating as Varasmus Division, is an international for-profit manufacturer headquartered in Ottawa, Ontario, Canada, that specializes in high-pressure homogenizers and cell disruptor instruments for laboratory research applications. The company has maintained federal vendor registration since March 2005 and holds an established track record supplying specialized equipment to multiple federal agencies. Avestin provides critical equipment and instrumentation to support federal research operations, with a particular focus on delivering advanced laboratory technology solutions to support biomedical and pharmaceutical research initiatives across the Department of Defense and health-related federal agencies.
Over the past several years, Avestin Inc. has secured four prime federal contract awards totaling approximately $114,154, each awarded as sole-source purchase orders without set-aside designations. The company supplied EmulsiFlex-C3 and EmulsiFlex-C5 high-pressure homogenizer systems to the Naval Health Research Center (Department of Defense, Bureau of Medicine and Surgery) for $35,279 in September 2025, to the Food and Drug Administration for $25,000 in May 2021, to the National Heart Lung and Blood Institute for $22,733 in March 2021 to support COVID-19 research on SARS-CoV-2 N-protein interactions, and to the National Institute on Drug Abuse for $31,142 in September 2022. These contracts reflect Avestin's specialization in providing high-pressure homogenization and cell disruption technology essential for advanced laboratory research, with funding spanning multiple federal agencies including the National Institutes of Health components, Food and Drug Administration, Department of Defense, and the Bureau of Medicine and Surgery.
Quick answers
What is Avestin Inc.'s UEI?
Avestin Inc.'s Unique Entity ID (UEI) in SAM.gov is PU2WZHYHTL85.
What is Avestin Inc.'s CAGE code?
Avestin Inc.'s CAGE code is L0ZC1.
What is Avestin Inc.'s primary NAICS code?
Avestin Inc.'s primary NAICS code is 333996 (Fluid Power Pump and Motor Manufacturing).
Where is Avestin Inc. located?
Avestin Inc.'s physical address in SAM.gov is 2450 Don Reid Dr, Ottawa, ON K1H 1E1, Canada.
Is Avestin Inc. registered in SAM.gov?
Yes. Avestin Inc.'s SAM.gov registration is active through February 3, 2027.
What is Avestin Inc.'s most recent federal award?
Avestin Inc.'s most recent federal contract award is Avestin emulsiflex-C3 (N6311625P0579), from Bureau of Medicine and Surgery, on September 2, 2025.
On GovTribe
See Avestin Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors